Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis Arising from Gastric Cancer

Archives of Surgery

Volumn 139, Issue 1, 2004, Pages 20-26

  Glehen, O ^a,b   Schreiber, V ^b   Cotte, E ^b   Sayag Beaujard, A C ^a   Osinsky, D ^a   Freyer, G ^a   Francois Y ^a   Vignal, J ^a   Gilly, François Noël ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; ASCITES; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0347628945     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.1.20     Document Type: Article

References (31)

1. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 1994;14:2131-2134.
2. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363.
3. Hanazaki K, Mochizuki Y, Machida T, et al, Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer. Hepatogastroenterology. 1999; 46:1238-1243.
4. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. Cancer. 1989;63:364-367.
5. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. New approach to management of malignant ascitis with a streptococcal preparation OK 432: improvement of host immunity and prolongation of survival. Surgery. 1983;93:357-353.
6. Rosen HR, Jatzko G, Repse S, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol. 1998;16:2733-2738.
7. Noh SH, Yoo CH, Chung HC, et al. Early postoperative intraperitoneal chernotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Oncology. 2001;60:24-30.
8. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding. Oncology. 2000;58:96-107.
9. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer. 1997;79:884-891.
10. Gilly FN, Carry PY, Sayag AC, et al. Tolerance of intraperitoneal chemohyperthermia with mitomycin C. Int J Hyperthermia. 1992;8:659-666.
11. Sayag-Beaujard AC, Francois Y, Glehen O, et al. Intraperitoneal chemohyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res. 1999;19:1375-1382.
12. Gilly FN, Carry PY, Sayag AC, et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology. 1994;41:124-129.
13. Gilly FN, Beaujard A, Glehen O, et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res. 1999;19:2317-2321.
14. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29-42.
15. Panteix G, Guillaumont M, Cherpin L, et al, Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology. 1993;50:366-370.
16. Hermanek P, Sobin LH. TNM Classification of Malignant Tumors. 4th ed. Geneva, Switzerland: Springer-Verlag; 1987.
17. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res. 1981;41:1096-1099.
18. Hirose K, Katayama K, lida A, et al. Efficacy of continuous hyperthermic periloneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer. Oncology. 1999;57:106-114.
19. Kunisaki C, Shimada H, Nomura M, et al. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery. 2002;131:521-528.
20. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92:71-76.
21. Barakat RR, Sabbatini P, Bhaskaran D, et al. Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol. 2002;20:694-698.
22. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999; 6:790-796.
23. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 1996;119:437-444.
24. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg. 2000;66:561-568.
25. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol. 2003;21:799-806.
26. Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg. 2003;138:26-33.
27. Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemoperfusion (IHCP). Gastric Cancer. 2001;4:27-33.
28. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: final results of a randomized controlled study. Cancer. 1994;73:2048-2052.
29. Yonemura Y, de Aretxabala X, Fujimura T, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology. 2001;48:1776-1782.
30. Samel S, Singal A, Becker H, Post S. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol. 2000; 26:222-226.
31. Schuhmacher CP, Fink U, Becker K, et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum: closing results after 5 years of follow-up. Cancer. 2001;91:918-927.